Central Asia vs United Republic of Tanzania: Proportion of the target population who received the final dose of
Central Asia
59.0%
in 2024
United Republic of Tanzania
94.0%
in 2024
Central Asia rank
8th
United Republic of Tanzania rank
5th
Proportion of the target population who received the final dose of over time
- Central Asia
- United Republic of Tanzania
How they compare
United Republic of Tanzania currently reports 94.0% against 59.0% in Central Asia, a difference of 35.0%.
That makes United Republic of Tanzania's figure about 1.6 times Central Asia's.
Across all 7 years both countries report, United Republic of Tanzania has been ahead every year.
Central Asia ranks 8th and United Republic of Tanzania ranks 5th of 35 groups.
United Republic of Tanzania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Central Asia | United Republic of Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.0% | 33.0% | 25.0% | United Republic of Tanzania |
| 2020s | 52.0% | 71.8% | 19.8% | United Republic of Tanzania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Central Asia or United Republic of Tanzania?
- United Republic of Tanzania, at 94.0% against 59.0% in Central Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Central Asia and United Republic of Tanzania?
- 35.0%, with United Republic of Tanzania ahead.
- How many years of comparable data are there for Central Asia and United Republic of Tanzania?
- 7 years are reported by both, from 2018 to 2024.
- How do Central Asia and United Republic of Tanzania rank globally for proportion of the target population who received the final dose of?
- Central Asia ranks 8th and United Republic of Tanzania ranks 5th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.